Masiviera
Country: European Union
Language: Czech
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
23-05-2014
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
masitinib
Available from:
AB Science
ATC code:
L01XE
INN (International Name):
masitinib
Therapeutic group:
Inhibitory proteinkinázy
Therapeutic area:
Pankreatické novotvary
Therapeutic indications:
Léčba non resekabilním lokálně pokročilým nebo metastazujícím karcinomem pankreatu.
Authorization status:
Odmítl
